Astellas Pharma Inc 2018 AR2
The report highlights Astellas Pharma Inc.'s strategic and financial performance for fiscal year 2017, alongside its transition to a Focus Area approach in research and development. Key achievements include maximizing the value of core products like XTANDI and overactive bladder treatments, while establishing the Rx+ Business Accelerator to develop healthcare solutions beyond prescription pharmaceuticals. On the sustainability front, the company updated its CSR Materiality Matrix, committed to the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions by 30% by fiscal 2030, and continued its support for global health initiatives such as ACTION ON FISTULA in Kenya. Additionally, Astellas transitioned to a corporate governance system with an Audit & Supervisory Committee to enhance management agility and oversight.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2018
Type: AR2
Pages: 158
Back to company
Astellas Pharma Inc
Annual Report
The report highlights Astellas Pharma Inc.'s strategic and financial performance for fiscal year 2017, alongside its transition to a Focus Area approach in research and development. Key achievements include maximizing the value of core products like XTANDI and overactive bladder treatments, while establishing the Rx+ Business Accelerator to develop healthcare solutions beyond prescription pharmaceuticals. On the sustainability front, the company updated its CSR Materiality Matrix, committed to the Science Based Targets initiative (SBTi) to reduce greenhouse gas emissions by 30% by fiscal 2030, and continued its support for global health initiatives such as ACTION ON FISTULA in Kenya. Additionally, Astellas transitioned to a corporate governance system with an Audit & Supervisory Committee to enhance management agility and oversight.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2017
Published
Sep 1, 2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Workplace Fatalities
Employees